Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 210.48 ($2.79) and traded as low as GBX 194 ($2.57). Spire Healthcare Group shares last traded at GBX 198.48 ($2.63), with a volume of 648,433 shares traded.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft decreased their target price on Spire Healthcare Group from GBX 320 ($4.25) to GBX 300 ($3.98) and set a "buy" rating for the company in a research report on Thursday, March 6th.
Read Our Latest Stock Report on Spire Healthcare Group
Spire Healthcare Group Trading Down 0.6%
The stock has a market cap of £792.70 million, a price-to-earnings ratio of 28.09, a PEG ratio of 1.06 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The business has a 50-day moving average of GBX 183.96 and a 200-day moving average of GBX 210.48.
Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The company reported GBX 8.80 ($0.12) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, research analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.
Spire Healthcare Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, June 20th. Investors of record on Thursday, May 22nd will be given a dividend of GBX 2.30 ($0.03) per share. This is a boost from Spire Healthcare Group's previous dividend of $2.10. The ex-dividend date of this dividend is Thursday, May 22nd. This represents a yield of 1.29%. Spire Healthcare Group's dividend payout ratio (DPR) is presently 42.70%.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
